<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors conducted a study of the <z:chebi fb="11" ids="18295">histamine</z:chebi> system (H), diaminoxidase (DO), histaminopexic index (HPI) using the biological method in 127 patients with <z:e sem="disease" ids="C0020538" disease_type="Disease or Syndrome" abbrv="HTN">hypertensive disease</z:e> and cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> with brain circulation disturbances and in 23 patients with atherosclerotic <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It was displayed that in the majority of the patients the H level and HPI value were pathologically changed, but DO activity was disturbed to a lesser degree </plain></SENT>
<SENT sid="2" pm="."><plain>The authors demonstrated some correlations between the fluctuations of H-DO-HPI system and the character of the brain circulation disturbances, the period of the <z:hpo ids='HP_0001297'>stroke</z:hpo>, severity of the disease and an etiological factor </plain></SENT>
<SENT sid="3" pm="."><plain>According to the authors' opinion changes in H-DO-HPI system were in a direct correlation with fluctuations of the level in the biological fluids of catecholimes, <z:chebi fb="19" ids="28790">serotonin</z:chebi>, <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>, <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Recommendations concerning a discontinuation of histaminemia or its negative effects were given </plain></SENT>
</text></document>